|
1
|
Wang T, Nelson RA, Bogardus A and Grannis
FW Jr: Five-year lung cancer survival: Which advanced stage
nonsmall cell lung cancer patients attain long-term survival?
Cancer. 116:1518–1525. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tracey E, Roder D, Zorbas H, Villanueva E,
Jelfs P and Bishop J: Survival and degree of spread for female
breast cancers in New South Wales from 1980 to 2003: Implications
for cancer control. Cancer Causes Control. 19:1121–1130. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Levy A and Doyen J: Metformin for
non-small cell lung cancer patients: Opportunities and pitfalls.
Crit Rev Oncol Hematol. 125:41–47. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeSantis CE, Siegel RL, Sauer AG, Miller
KD, Fedewa SA, Alcaraz KI and Jemal A: Cancer statistics for
African Americans, 2016: Progress and opportunities in reducing
racial disparities. CA Cancer J Clin. 66:290–308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Herbst RS, Baas P, Kim DW, Felip E,
Pérez-Gracia JL, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, et al:
Pembrolizumab versus docetaxel for previously treated,
PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010):
A randomised controlled trial. Lancet. 387:1540–50. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa
K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, et al:
First-line crizotinib versus chemotherapy in ALK-positive lung
cancer. N Engl J Med. 371:2167–2177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chu C, Spitale RC and Chang HY:
Technologies to probe functions and mechanisms of long noncoding
RNAs. Nat Struct Mol Biol. 22:29–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hutchinson JN, Ensminger AW, Clemson CM,
Lynch CR, Lawrence JB and Chess A: A screen for nuclear transcripts
identifies two linked noncoding RNAs associated with SC35 splicing
domains. BMC Genomics. 8:392007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yunusov D, Anderson L, DaSilva LF, Wysocka
J, Ezashi T, Roberts RM and Verjovski-Almeida S: HIPSTR and
thousands of lncRNAs are heterogeneously expressed in human
embryos, primordial germ cells and stable cell lines. Sci Rep.
6:327532016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clark MB and Mattick JS: Long noncoding
RNAs in cell biology. Semin Cell Dev Biol. 22:366–376. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen J, Wang R, Zhang K and Chen LB: Long
non-coding RNAs in non-small cell lung cancer as biomarkers and
therapeutic targets. J Cell Mol Med. 18:2425–2436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hou Z, Zhao W, Zhou J, Shen L, Zhan P, Xu
C, Chang C, Bi H, Zou J, Yao X, et al: A long noncoding RNA Sox2ot
regulates lung cancer cell proliferation and is a prognostic
indicator of poor survival. Int J Biochem Cell Biol. 53:380–388.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Z, Shen J, Chan MTV and Wu WKK: The
long non-coding RNA SPRY4-IT1: An emerging player in tumorigenesis
and osteosarcoma. Cell Prolif. 51:e124462018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang F, Wen C, Zhuansun Y, Huang L, Chen
W, Yang X and Liu H: A novel long noncoding RNA OECC promotes
colorectal cancer development and is negatively regulated by
miR-143-3p. Biochem Biophys Res Commun. 503:2949–2955. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mari-Alexandre J, Diaz-Lagares A, Villalba
M, Juan O, Crujeiras AB, Calvo A and Sandoval J: Translating cancer
epigenomics into the clinic: Focus on lung cancer. Transl Res.
189:76–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin H, Cheng W, Yan H and Zhang X:
Overexpression of the long noncoding RNA CCAT1 promotes metastasis
via epithelial-to-mesenchymal transition in lung adenocarcinoma.
Oncol Lett. 16:1809–1814. 2018.PubMed/NCBI
|
|
21
|
Xu C, Xiao G, Zhang B, Wang M, Wang J, Liu
D, Zhang J, Ren H and Sun X: CCAT1 stimulation of the symmetric
division of NSCLC stem cells through activation of the Wnt
signalling cascade. Gene Ther. 25:4–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu B, Zhang H, Wang Z, Zhang F, Wei H and
Li L: LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance
in non-small-cell lung cancer cell line by targeting SOX4. Cancer
Biol Ther. 18:974–983. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
King D, Yeomanson D and Bryant HE: PI3King
the lock: Targeting the PI3K/Akt/mTOR pathway as a novel
therapeutic strategy in neuroblastoma. J Pediatr Hematol Oncol.
37:245–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rafalski VA and Brunet A: Energy
metabolism in adult neural stem cell fate. Prog Neurobiol.
93:182–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Man HY, Wang Q, Lu WY, Ju W, Ahmadian G,
Liu L, D'Souza S, Wong TP, Taghibiglou C, Lu J, et al: Activation
of PI3-kinase is required for AMPA receptor insertion during LTP of
mEPSCs in cultured hippocampal neurons. Neuron. 38:611–624. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koirala P, Huang J, Ho TT, Wu F, Ding X
and Mo YY: LncRNA AK023948 is a positive regulator of AKT. Nat
Commun. 8:144222017. View Article : Google Scholar : PubMed/NCBI
|
